GHMC Commissioner RV Karnan directed 100% collection of e-waste and bio-medical waste across Hyderabad, warning of strict ...

Cabaletta Bio (NASDAQ:CABA) used a fireside chat at TD Cowen’s 46th Annual Health Care Conference to highlight progress ...

Syntis Bio has dosed the first patient in the SYNTIETY-1 Phase I/Ib trial of SYNT-101, its investigational once-daily oral ...

With our Phase IIa program underway and defined milestones in front of us, we look forward to engaging with investors and potential partners at BIO.” — Christer Rosén, Chairman and Chief Executive ...

Financing led by new investor Venrock Healthcare Capital Partners, with participation from new and existing investors Proceeds support the achievement of value inflection points for multiple RNA editi ...

Series B funds will enable clinical development of ATV-1601, an oral allosteric AKT1-selective inhibitor for the treatment of Hereditary Hemorrhagic Telangiectasia (HHT), and the advancement of its ...

Chemical companies streamline polyamide operations while investing in specialty polymers and sustainable manufacturing ...

Fintel reports that on March 5, 2026, Wedbush initiated coverage of Climb Bio (NasdaqGM:CLYM) with a Outperform recommendation. Analyst Price Forecast Suggests 60.13% Upside As of February 26, 2026, ...

Ooops... Something went wrong while loading this page.

Year-End Cash Position, License Renewal Activity and Receivables Collections Provide Sound Financial Position to Support Growth ...

Thank you for joining today's call to discuss our fourth quarter and full year 2025 financial results. 2025 was a year of ...

Manures are the organic materials derived from animal, human and plant residues which contain plant nutrients in complex organic forms ...